Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.
Saved in:
| Title: | Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults. |
|---|---|
| Authors: | Green CA; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom. Electronic address: christopher.green@paediatrics.ox.uk., Sande CJ; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Scarselli E; Nouscom Srl, via di Castel Romano 100, 00128 Roma, Italy., Capone S; ReiThera Srl, Via di Castel Romano 100, 00128 Roma, Italy., Vitelli A; ReiThera Srl, Via di Castel Romano 100, 00128 Roma, Italy., Nicosia A; Keires AG, Baumleingasse 18, CH 4051 Basel, Switzerland; CEINGE, Via Gaetano Salvatore 486, 80145 Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy., Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Thompson AJ; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., de Lara CM; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom., Taylor KS; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, United Kingdom., Haworth K; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Hutchings CL; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom., Cargill T; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom., Angus B; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Klenerman P; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom. |
| Source: | The Journal of infection [J Infect] 2019 May; Vol. 78 (5), pp. 382-392. Date of Electronic Publication: 2019 Feb 08. |
| Publication Type: | Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30742894 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Green+CA%22">Green CA</searchLink>; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom. Electronic address: christopher.green@paediatrics.ox.uk.<br /><searchLink fieldCode="AU" term="%22Sande+CJ%22">Sande CJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Scarselli+E%22">Scarselli E</searchLink>; Nouscom Srl, via di Castel Romano 100, 00128 Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Capone+S%22">Capone S</searchLink>; ReiThera Srl, Via di Castel Romano 100, 00128 Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Vitelli+A%22">Vitelli A</searchLink>; ReiThera Srl, Via di Castel Romano 100, 00128 Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Nicosia+A%22">Nicosia A</searchLink>; Keires AG, Baumleingasse 18, CH 4051 Basel, Switzerland; CEINGE, Via Gaetano Salvatore 486, 80145 Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Silva-Reyes+L%22">Silva-Reyes L</searchLink>; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thompson+AJ%22">Thompson AJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22de+Lara+CM%22">de Lara CM</searchLink>; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Taylor+KS%22">Taylor KS</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Haworth+K%22">Haworth K</searchLink>; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hutchings+CL%22">Hutchings CL</searchLink>; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cargill+T%22">Cargill T</searchLink>; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Angus+B%22">Angus B</searchLink>; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Klenerman+P%22">Klenerman P</searchLink>; Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Peter Medawar building, Oxford OX1 3SY, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pollard+AJ%22">Pollard AJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227908424%22">The Journal of infection</searchLink> [J Infect] 2019 May; Vol. 78 (5), pp. 382-392. <i>Date of Electronic Publication: </i>2019 Feb 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22W%2EB%2E+Saunders%22">W.B. Saunders </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7908424 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-2742 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201634453%22">01634453 </searchLink><i>NLM ISO Abbreviation: </i>J Infect <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30742894 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jinf.2019.02.003 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 382 Titles: – TitleFull: Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Green CA – PersonEntity: Name: NameFull: Sande CJ – PersonEntity: Name: NameFull: Scarselli E – PersonEntity: Name: NameFull: Capone S – PersonEntity: Name: NameFull: Vitelli A – PersonEntity: Name: NameFull: Nicosia A – PersonEntity: Name: NameFull: Silva-Reyes L – PersonEntity: Name: NameFull: Thompson AJ – PersonEntity: Name: NameFull: de Lara CM – PersonEntity: Name: NameFull: Taylor KS – PersonEntity: Name: NameFull: Haworth K – PersonEntity: Name: NameFull: Hutchings CL – PersonEntity: Name: NameFull: Cargill T – PersonEntity: Name: NameFull: Angus B – PersonEntity: Name: NameFull: Klenerman P – PersonEntity: Name: NameFull: Pollard AJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1532-2742 Numbering: – Type: volume Value: 78 – Type: issue Value: 5 Titles: – TitleFull: The Journal of infection Type: main |
| ResultId | 1 |
